•Trivitron Healthcare has joined hands with India Value
Fund Advisors (IVFA) to finance its next phase of
growth. IVFA has invested Rs 150 crore (US$ 24.12
million) for a minority stake in the company.
•IDFC Alternatives has invested Rs 125 crore (US$
20.10 million) in Medi Assist Healthcare, a development that continues to reiterate risk capital's strong focus on the sector.
•Cadila Pharmaceuticals Ltd (CPL) has decided to invest another Rs 100 crore (US$ 16.08 million) on expansion, upgradation and modernisation of its manufacturing unit at Samba in Jammu district.
•Apollo Hospitals and Medtronic Inc are to collaborate to bring an innovative, affordable and portable haemodialysis system in India that can help improve access to care for end stage renal disease (ESRD) patients who need renal replacement therapy. Medtronic intends to develop and manufacture key components of this haemodialysis system in India which will be ready for commercial launch in 2016, the companies said in a joint statement.